Baby Chakraborty, KalimNews, Delhi, November 10, 2024: Johnson & Johnson, the renowned healthcare giant known for its baby powder, has been hit with a significant legal ruling, ordered to pay ₹180 crore (USD 24 million) in damages after a Connecticut court found its iconic product contained harmful asbestos. The case, filed by plaintiff Ivan Plotkin, who developed mesothelioma—a rare cancer linked to asbestos—after using the baby powder, has raised serious concerns about the safety of the product.
Plotkin claimed that years of using Johnson & Johnson’s baby powder led to his diagnosis, and his legal team argued that the product was contaminated with asbestos fibers, posing a health risk. Despite Johnson & Johnson’s defense that their product was asbestos-free, the court sided with the plaintiff, highlighting the potential dangers of the company’s talc-based powder.
The lawsuit focuses on allegations that Johnson & Johnson’s baby powder contained trace amounts of asbestos, a carcinogen known to cause cancer. These claims are not new; previous investigations have uncovered evidence that the company’s talc products were, at times, contaminated with asbestos between the 1970s and early 2000s. In fact, internal documents from Johnson & Johnson revealed that several tests showed contamination with asbestos, a fact not disclosed to the public or regulatory bodies.
The company has consistently denied these claims, maintaining that its baby powder is safe and free of asbestos. Johnson & Johnson’s defense also argues that independent scientific evaluations confirm the safety of their product.
This ruling is just the latest chapter in a series of lawsuits against Johnson & Johnson over its talc-based products. The company has faced over 61,000 lawsuits from individuals claiming their talc products caused cancers like ovarian cancer and mesothelioma. In 2018, a Missouri court awarded nearly $4.7 billion in damages to 22 women who alleged the powder contributed to their ovarian cancer.
Johnson & Johnson has withdrawn its talc-based products from the U.S. market in 2020 but continues to face legal scrutiny worldwide, particularly in markets like India and Bangladesh, where the baby powder has been widely used for decades.
Johnson & Johnson is currently engaged in bankruptcy proceedings to manage its talc-related liabilities, including a nearly $9 billion settlement attempt for ovarian cancer claims. However, mesothelioma cases like Plotkin’s are not part of this settlement, and the company faces continued litigation.
Despite the legal pressure, Johnson & Johnson has vowed to appeal the ruling and maintain that its talc products are safe, asserting that the verdict is “irreconcilable with decades of scientific evidence.” The company is also dealing with a $700 million settlement in the U.S., addressing accusations from 42 states over misleading consumers about the safety of its talc-based products.
As the company faces mounting legal and reputational challenges, the public’s concern over the safety of its once-legendary baby powder continues to grow. The outcome of this ongoing litigation will likely have significant implications for the future of Johnson & Johnson and its iconic product line.